However, in a research of Palazon et al., they found deletion of VEGFA in CD8+ T cell enhanced tumor growth, which was explained by the VEGF-deficient CTLs’ intrinsic defect in acquisition of effector phenotypes (47). The gene discussed is CD8A; the disease is neoplasm.